Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages
- PMID: 16142741
- DOI: 10.1002/art.21228
Effectiveness of anti-folate receptor beta antibody conjugated with truncated Pseudomonas exotoxin in the targeting of rheumatoid arthritis synovial macrophages
Abstract
Objective: To define the distribution of folate receptor beta (FRbeta)-expressing cells in various tissues, including rheumatoid arthritis (RA) synovial tissues, and to verify the effects of an immunotoxin composed of an anti-FRbeta monoclonal antibody (mAb) and truncated Pseudomonas exotoxin A (PEA) on apoptosis and tumor necrosis factor alpha (TNFalpha) production by adherent synovial mononuclear cells from RA patients.
Methods: Anti-FRbeta mAb were produced by immunizing mice with FRbeta-transfected murine pre-B cells. The distribution of the FRbeta antigen was examined by immunohistochemical analysis using anti-FRbeta mAb and macrophage-specific anti-CD163 mAb. Anti-FRbeta mAb was chemically crosslinked with truncated PEA. FRbeta-expressing macrophages were produced by the transfection of adenovirus vector containing the FRbeta gene. Apoptotic cells were detected by staining with propidium iodide. TNFalpha was measured by enzyme-linked immunosorbent assay.
Results: FRbeta-expressing cells were not present in peripheral blood leukocytes and their activated cells. In all of the tissues examined, most FRbeta-expressing cells were CD163+. The immunotoxin significantly induced the apoptosis of FRbeta-transfected macrophages and adherent RA synovial mononuclear cells and inhibited TNFalpha production by adherent RA synovial mononuclear cells.
Conclusion: We demonstrated the limited distribution of FRbeta-expressing cells in various tissues. The immunotoxin targeting FRbeta-expressing cells will provide a therapeutic tool for rheumatoid synovitis.
Similar articles
-
In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferation of rheumatoid arthritis synovial cells.Arthritis Rheum. 2006 Oct;54(10):3126-34. doi: 10.1002/art.22082. Arthritis Rheum. 2006. PMID: 17009233
-
Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.Clin Exp Immunol. 2010 Aug;161(2):348-56. doi: 10.1111/j.1365-2249.2010.04182.x. Epub 2010 Jun 9. Clin Exp Immunol. 2010. PMID: 20550546 Free PMC article.
-
Efficacy of an immunotoxin to folate receptor beta in the intra-articular treatment of antigen-induced arthritis.Arthritis Res Ther. 2012 May 2;14(3):R106. doi: 10.1186/ar3831. Arthritis Res Ther. 2012. PMID: 22551402 Free PMC article.
-
Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy.Biomolecules. 2020 Jun 30;10(7):979. doi: 10.3390/biom10070979. Biomolecules. 2020. PMID: 32630017 Free PMC article. Review.
-
The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis.Drug Deliv Transl Res. 2019 Feb;9(1):366-378. doi: 10.1007/s13346-018-0589-2. Drug Deliv Transl Res. 2019. PMID: 30280318 Free PMC article. Review.
Cited by
-
Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1.Cells. 2020 Jun 10;9(6):1445. doi: 10.3390/cells9061445. Cells. 2020. PMID: 32532019 Free PMC article.
-
Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.Mol Pharm. 2014 Dec 1;11(12):4425-36. doi: 10.1021/mp500565q. Epub 2014 Oct 27. Mol Pharm. 2014. PMID: 25314115 Free PMC article.
-
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy.Nat Commun. 2021 Feb 9;12(1):877. doi: 10.1038/s41467-021-20893-2. Nat Commun. 2021. PMID: 33563975 Free PMC article.
-
Serum-soluble folate receptor β as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.Clin Rheumatol. 2018 Nov;37(11):2939-2945. doi: 10.1007/s10067-018-4202-3. Epub 2018 Jul 18. Clin Rheumatol. 2018. PMID: 30022370
-
Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.Arthritis Res Ther. 2011 Apr 4;13(2):R56. doi: 10.1186/ar3304. Arthritis Res Ther. 2011. PMID: 21463515 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials